Header Logo

Connection

CHITRA HOSING to Neoplasm Proteins

Back to Details
This is a "connection" page, showing publications CHITRA HOSING has written about Neoplasm Proteins.
CHITRA HOSING
Connection Strength
0.015
Neoplasm Proteins
  1. Phase 2 study of low-dose clofarabine plus cytarabine for patients with higher-risk myelodysplastic syndrome who have relapsed or are refractory to hypomethylating agents. Cancer. 2017 Feb 15; 123(4):629-637.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.